(Q37866291)

24 August 2017

1 reference

title

Aripiprazole: in the treatment of irritability associated with autistic disorder in pediatric patients (English)

1 reference

24 August 2017

0 references

1

Monique P Curran

1 reference

24 August 2017

publication date

1 June 2011

1 reference

24 August 2017

1 reference

24 August 2017

volume

13

1 reference

24 August 2017

issue

3

1 reference

24 August 2017

page(s)

197-204

1 reference

https://scigraph.springernature.com/pub.10.2165/11207230-000000000-00000

24 August 2017

exact match

0 references

cites work

An open-label study of aripiprazole: pharmacokinetics, tolerability, and effectiveness in children and adolescents with conduct disorder

1 reference

https://api.crossref.org/works/10.2165%2F11207230-000000000-00000

Practice parameters for the assessment and treatment of children, adolescents, and adults with autism and other pervasive developmental disorders. American Academy of Child and Adolescent Psychiatry Working Group on Quality Issues

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11207230-000000000-00000

The role of antipsychotics in the management of behavioural symptoms in children and adolescents with autism

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11207230-000000000-00000

Aripiprazole: in adolescents with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11207230-000000000-00000

Aripiprazole: a review of its use in schizophrenia and schizoaffective disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11207230-000000000-00000

Aripiprazole: a novel atypical antipsychotic drug with a uniquely robust pharmacology.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11207230-000000000-00000

Dopamine D2 and D3 receptor occupancy in normal humans treated with the antipsychotic drug aripiprazole (OPC 14597): a study using positron emission tomography and [11C]raclopride

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11207230-000000000-00000

Pharmacokinetics, tolerability, and safety of aripiprazole following multiple oral dosing in normal healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11207230-000000000-00000

Aripiprazole in the treatment of irritability in children and adolescents with autistic disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11207230-000000000-00000

A placebo-controlled, fixed-dose study of aripiprazole in children and adolescents with irritability associated with autistic disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11207230-000000000-00000

Autism Diagnostic Interview-Revised: a revised version of a diagnostic interview for caregivers of individuals with possible pervasive developmental disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11207230-000000000-00000

Line-item analysis of the Aberrant Behavior Checklist: results from two studies of aripiprazole in the treatment of irritability associated with autistic disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11207230-000000000-00000

A rating scale for drug-induced akathisia

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11207230-000000000-00000

Pharmacokinetics of Aripiprazole and Concomitant Carbamazepine

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11207230-000000000-00000

Safety and tolerability of aripiprazole in the treatment of irritability associated with autistic disorder in pediatric subjects (6-17 years old):results from a pooled analysis of 2 studies

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21500873

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

A rating scale for extrapyramidal side effects

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21500873

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Aripiprazole: in acute mania associated with bipolar I disorder

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21500873

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.2165/11207230-000000000-00000

1 reference

24 August 2017

1 reference